tiprankstipranks
Trending News
More News >
International Flavors & Fragrances (IFF)
NYSE:IFF
US Market

International Flavors & Fragrances (IFF) Earnings Dates, Call Summary & Reports

Compare
819 Followers

Earnings Data

Report Date
May 11, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
1.08
Last Year’s EPS
1.2
Same Quarter Last Year
Based on 13 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 11, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call highlights meaningful progress on balance sheet strengthening, disciplined capital allocation, margin expansion and targeted reinvestment in R&D and capacity—supported by solid segment-level wins in Taste, Scent (Fine Fragrance) and pockets of Health & Biosciences. These positives are tempered by continued top-line pressure and profitability volatility in Food Ingredients (notably Q4 weakness), commodity pressure in Fragrance Ingredients, a sizable free cash flow shortfall in 2025 driven by transaction-related charges and working capital builds, and modest near-term 2026 guidance with H1 comparability headwinds. Management has clear remediation plans (portfolio sales, productivity, innovation investments, cash-focused incentives) and expects improvements through 2026 and into 2027.
Company Guidance
The company guided 2026 sales of $10,500,000,000 to $10,800,000,000 (comparable currency‑neutral growth of 1%–4%) and EBITDA of $2,050,000,000 to $2,150,000,000 (comparable currency‑neutral EBITDA growth of 3%–8%), noting FX should be roughly +1 percentage point to sales and negligible to EBITDA; growth is expected to be volume‑driven (incremental margins on volume ~30%–35%), led by Taste, Health & Biosciences and Scent, with modest EBITDA growth expected in Q1 versus a like‑for‑like Q1 2025 base of about $55,000,000 (adjusting for divestitures) and progressive improvement thereafter. Management expects CapEx of ~6% of sales, productivity to fund selective reinvestment, higher Reg G/one‑time costs as the Food Ingredients sale process progresses, improved operating cash flow generation excluding those items, an operating cash‑flow‑conversion incentive metric (EBITDA − CapEx − change in net working capital), and intends to use potential sale proceeds to buy back shares and pay down debt while keeping net debt/credit‑adjusted EBITDA below a ~3.0x target (net debt/credit‑adjusted EBITDA was 2.6x at year‑end 2025).
Improved Leverage and Balance Sheet
Net debt to credit-adjusted EBITDA improved to 2.6x (from 3.8x in 2024); gross debt reduced to ~$6.0B (down nearly $3.0B vs 2024); cash & equivalents of $590M.
Consolidated Profitability Expansion
Full-year EBITDA grew ~7% with ~100 basis points of EBITDA margin expansion; Q4 EBITDA was $437M, a ~7% increase, and Q4 EBITDA margin improved ~90 basis points to 16.9%.
Taste Segment Strength
Full-year Taste sales up ~4% (two-year avg growth ~4%); Q4 Taste sales $588M (+2%) with Q4 EBITDA up ~17% to $94M, driven by new wins, favorable net pricing and productivity.
Health & Biosciences Momentum
Full-year Health & Biosciences sales improved (management cited ~3% full-year improvement) with EBITDA up ~7% for the year; Q4 sales $589M (+5%) and Q4 EBITDA increased ~20% to $155M, led by Food Biosciences, Animal Nutrition and Home & Personal Care.
Scent Performance and Higher‑Value Mix
Full-year Scent sales +3% with EBITDA +2%; Q4 Scent sales $610M (+4%): Fine Fragrance +10% and Consumer Fragrance mid-single-digit growth, indicating strength in higher-margin areas.
Food Ingredients Margin Improvement (Full Year)
Although full-year Food Ingredients sales were down, the business delivered ~10% EBITDA growth and ~150 basis points of EBITDA margin expansion for the full year, reflecting margin improvement through portfolio actions and productivity.
Active Portfolio Optimization
Completed divestitures (Pharma Solutions, nitrocellulose, René Laurent), agreement to sell soy crush concentrates & lecithin to Bunge (expected by April), and formally launched a competitive sale process for Food Ingredients with meaningful interest from strategics and financial sponsors.
Investment in Innovation and Capacity
Invested ~ $100M in R&D in 2025; CapEx totaled $594M (~5.5% of sales) in 2025 and planned CapEx ~6% of sales in 2026; launched new technologies (EnviroCAPS biodegradable encapsulation, 'Super Carrot' umami ingredient) and are investing in enzyme capacity, naturals, biotech and AI.
Cash Return & Capital Allocation Discipline
Returned $409M via dividends and $38M in share repurchases (program started in Q4); management intends to use potential Food Ingredients sale proceeds to reduce dilution and pay down debt while keeping net leverage below 3.0x.

International Flavors & Fragrances (IFF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

IFF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 11, 2026
2026 (Q1)
1.08 / -
1.2
Feb 11, 2026
2025 (Q4)
0.83 / 0.80
0.97-17.53% (-0.17)
Nov 04, 2025
2025 (Q3)
1.02 / 1.05
1.040.96% (+0.01)
Aug 05, 2025
2025 (Q2)
1.12 / 1.15
1.16-0.86% (-0.01)
May 06, 2025
2025 (Q1)
1.14 / 1.20
1.136.19% (+0.07)
Feb 18, 2025
2024 (Q4)
0.81 / 0.97
0.7234.72% (+0.25)
Nov 05, 2024
2024 (Q3)
1.07 / 1.04
0.8916.85% (+0.15)
Aug 06, 2024
2024 (Q2)
0.99 / 1.16
0.8634.88% (+0.30)
May 06, 2024
2024 (Q1)
0.86 / 1.13
0.8729.89% (+0.26)
Feb 20, 2024
2023 (Q4)
0.76 / 0.72
0.97-25.77% (-0.25)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

IFF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 11, 2026
$76.97$81.50+5.89%
Nov 04, 2025
$61.11$63.61+4.09%
Aug 05, 2025
$69.72$65.32-6.31%
May 06, 2025
$77.78$72.27-7.08%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does International Flavors & Fragrances (IFF) report earnings?
International Flavors & Fragrances (IFF) is schdueled to report earning on May 11, 2026, After Close (Confirmed).
    What is International Flavors & Fragrances (IFF) earnings time?
    International Flavors & Fragrances (IFF) earnings time is at May 11, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is IFF EPS forecast?
          IFF EPS forecast for the fiscal quarter 2026 (Q1) is 1.08.

            International Flavors & Fragrances (IFF) Earnings News

            IFF Earnings: International Flavors & Fragrances Plummets on Dividend Cut, Weak Guidance
            Premium
            Market News
            IFF Earnings: International Flavors & Fragrances Plummets on Dividend Cut, Weak Guidance
            2y ago
            International Flavors & Fragrances (NYSE:IFF) Plummets On Big Q2 Miss
            Premium
            Market News
            International Flavors & Fragrances (NYSE:IFF) Plummets On Big Q2 Miss
            3y ago